Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Return on Assets (2017 - 2021)

Historic Return on Assets for ENDRA Life Sciences (NDRA) over the last 5 years, with Q3 2021 value amounting to 0.64%.

  • ENDRA Life Sciences' Return on Assets rose 28400.0% to 0.64% in Q3 2021 from the same period last year, while for Sep 2021 it was 0.64%, marking a year-over-year increase of 28400.0%. This contributed to the annual value of 1.47% for FY2020, which is 3800.0% up from last year.
  • As of Q3 2021, ENDRA Life Sciences' Return on Assets stood at 0.64%, which was up 28400.0% from 0.61% recorded in Q2 2021.
  • In the past 5 years, ENDRA Life Sciences' Return on Assets registered a high of 0.49% during Q3 2017, and its lowest value of 6.06% during Q1 2017.
  • Its 5-year average for Return on Assets is 2.23%, with a median of 2.3% in 2018.
  • Within the past 5 years, the most significant YoY rise in ENDRA Life Sciences' Return on Assets was 45400bps (2018), while the steepest drop was -40000bps (2018).
  • ENDRA Life Sciences' Return on Assets (Quarter) stood at 0.79% in 2017, then crashed by -191bps to 2.3% in 2018, then fell by -7bps to 2.47% in 2019, then surged by 33bps to 1.66% in 2020, then surged by 62bps to 0.64% in 2021.
  • Its Return on Assets was 0.64% in Q3 2021, compared to 0.61% in Q2 2021 and 0.77% in Q1 2021.